Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...

Living with diabetes means being extra mindful of what you eat, but it doesn't mean your food has to be boring. In fact, making a few simple swaps can make a huge difference in managing your blood ...

Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks the cells in the pancreas that are responsible for producing insulin, leaving ...

Consumption of ultra-processed foods (UPFs) across South Asia varies significantly depending on location, age, gender, and ...

Since her 2021 diabetes diagnosis, Stephanie Guignard, a nurse practitioner, has made it her mission to educate people on how ...

Beware, these common Indian foods contain added sugars that can lead to sugar spikes and long-term risks like diabetes, weight gain, and fatigue.

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

A staple in any fridge, yoghurt comes in countless varieties, each claiming to be the healthier choice on Australian ...

Consuming products like hot dogs, commercial bread, and sweet treats could increase your risk for health problems — or even a ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...